1,2 Retatrutide isnt legally available in the UK as of May 2026
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
A study in C57BL/6 mice with intragastric administration of allulose at doses of 1 and 3 g per kg body weight described an increased GLP-1 secretion and a transient reduction in food intake that was no longer observed when animal lacking a GLP-1 receptor were used (Reference Hayakawa, Hira and Nakamura16)
So far, Novo Nordisks oral semaglutide and Lillys orforglipron are available
those switched to placebo regained about 14% over the next year. Weight loss slows toward a plateau on a held dose rather than continuing indefinitely
Approved medications are coordinated for direct delivery to your residence, saving you time and effort